Subchronic effects of ligands of cannabinoid receptors on learning and memory processes of olfactory bulbectomized rats

• Autorzy: Velikova M. , Doncheva D. , Teshev R.
• Języki publikacji: EN

Abstrakty

EN

The brain endocannabinoid system has been shown to play a role in many physiological processes, including mood, learning and memory. It is also involved in the pathogenesis of anxiety, depression, mood disorders, as well as neurodegenerative disorders, although the exact mechanisms by which cannabinoid receptors interfere in these disorders are not well established. The aim of the present study was to evaluate the effects of cannabinoid ligands HU‑210 (CB1 receptor agonist) and SR 141716A (CB1 receptor antagonist) on learning and memory processes of rats with depressive – like state, induced by bilateral olfactory bulbectomy. The bilateral olfactory bulbectomy (OBX) is a validated model of depression, which can be used also as an animal model of Alzheimer’s disease. We found that the subchronic treatment of OBX rats with HU 210 and SR 141716A exerted modulatory effect on rat’s performance in both active avoidance (shuttle box) and passive avoidance (step through) tests. HU 210 ameliorated the memory deficits of OBX rats; however, the scores of the sham‑operated controls had not been reached. SR 141716A modified the avoidance performance in OBX rats and showed a memory enhancing effect in the sham‑operated rats. Our findings suggest that CB1 receptors might be involved in avoidance learning and memory acquisition in OBX rats.

• Wydawca: -
• Czasopismo: Acta Neurobiologiae Experimentalis
• Rocznik: 2020
• Tom: 80
• Numer: 3
• Opis fizyczny: p.286-296,fig.,ref.

Twórcy

autor

Velikova M.

• Department of Physiology and Pathophysiology, Medical University, Varna, Bulgaria

autor

Doncheva D.

• Department of Physiology and Pathophysiology, Medical University, Varna, Bulgaria

autor

Teshev R.

• Department of Pathophysiology, Medical University of Sofia, Sofia, Bulgaria

Bibliografia

• Abush H, Akirav I (2010) Cannabinoids modulate hippocampal memory and plasticity. Hippocampus 20: 1126–1138.
• Aleksandrov IY, Kuvichkin VV, Kashparov IA, Medvinskaya NI, Nesterova IV, Lunin SM, Samokhin AN, Bobkova NV (2004) Increased level of β‑amy‑ loid in the brain of bulbectomized mice. Biochemistry 69: 176–180.
• Archer T, Söderberg U, Mohammed AK, Fredriksson A (1984) Active and passive avoidance performances following bilateral olfactory bulbecto‑ my. Scand J Psychol 25: 179–188.
• Baarendse PJJ, van Grootheest G, Jansen RF, Pieneman AW, Ögren SO,Ver‑ hage M, et al., (2008) Differential involvement of the dorsal hippocam‑ pusin passive avoidance in C57BL/6J and DBA/2J mice. Hippocampus 18: 11–19.
• Borgan F, Beck K, Butler E, McCutcheon R, Veronese M, Vernon A, Howes OD (2019) The effects of cannabinoid 1 receptor compounds on mem‑ ory: a meta‑analysis and systematic review across species. Psychophar‑ macology 236: 3257–3270.
• Borre Y, Lemstra S, Westphal KG, Morgan ME, Olivier B, Oosting RS (2012) Celecoxib delays cognitive decline in an animal model of neurodegener‑ ation. Behav Brain Res 234: 285–291.
• Buresova O, Bures J (1983) Techniques and basic experiments for the study of brain and behavior. Elsevier, Sci Publ, Amsterdam, New York. Burwell R, Saddoris M, Bucci D, Wiig K (2014) Corticohippocampal contri‑ butions to spatial and contextual learning. J Neurosci 24 : 3826–3836.
• Chhatwal JP, Davis M, Maguschak KA, Ressler KJ (2005) Enhancing canna‑ binoid neurotransmission augments the extinction of conditioned fear. Neuropsychopharmacology 30: 516–524.
• Choi JS, Cain CK, LeDoux JE (2010) The role of amygdala nuclei in the ex‑ pression of auditory signaled two‑way active avoidance in rats. Learn Mem 17: 139–147.
• De Petrocellis L, Di Marzo V (2009) An introduction to the endocannabinoid system: from the early to the latest concepts. Best Pract Res Clin Endo‑ crinol Metab 23: 1–15.
• Douma TN, Borre Y, Hendriksen H, Olivier B, Oosting RS (2011) Simvastatin improves learning and memory in control but not in olfactory bulbecto‑ mized rats. Psychopharmacology 216: 537–544.
• Eisenstein SA, Clapper JR, Holmes PV, Piomelli D, Hohmann AG (2010) A role for 2‑arachidonoylglycerol and endocannabinoid signaling in the locomotor response to novelty induced by olfactory bulbectomy. Phar‑ macol Res 61: 419–429.
• Eisenstein SA, Holmes PV, Hohmann AG (2009) Endocannabinoid modu‑ lation of amphetamine sensitization is disrupted in a rodent model of lesion-induced dopamine dysregulation. Synapse 63: 941–950.
• Fernández‑Ruiz J, Gómez‑Ruiz  M, García C, Hernández  M, Ramos JA (2017) Modeling neurodegenerative disorders for developing can‑ nabinoid‑based neuroprotective therapies. Methods Enzymol 593: 175–198.
• Fernandez‑Ruiz J, Moro MA, Martinez‑Orgado J (2015) Cannabinoids in neurodegenerative disorders and stroke/brain trauma: from preclinical models to clinical applications. Neurotherapeutics 12: 793–806.
• Franks KH, Chuah MI, King AE, Vickers JC (2015) Connectivity of Pathology: The olfactory system as a model for network‑driven mechanisms of Alz‑ heimer’s disease pathogenesis. Front Aging Neurosci 7: 234.
• Freund TF, Katona I, Piomelli D (2003) Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83: 1017–1066.
• Gomita Y, Ogawa N, Ueki S (1984) Effect of bilateral olfactory bulbecto‑ my on discrimination avoidance conditioning in rats. Physiol Behav 32: 1011–1016.
• Gozzani I, Isquierdo I (1976) Possible peripheral adrenergic and central do‑ paminergic influences in memory consolidation. Psychopharmacology 49: 109–111.
• Grecksch G, Zhou D, Franke C, Schröder U, Sabel B, Becker A, Huether G (1997) Influence of olfactory bulbectomy and subsequent imipramine treatment on 5‑hydroxytryptaminergic presynapses in the rat frontal cortex: behavioural correlates. Br J Pharmacol 122: 1725–1731.
• Haj‑Mirzaian A, Amini‑Khoei H, Haj‑Mirzaian A, Amiri S, Ghesmati  M, Zahir  M, Shafaroodi H, Dehpour AR (2017) Activation of cannabinoid receptors elicits antidepressant‑like effects in a mouse model of social isolation stress. Brain Res Bull 130: 200–210.
• Hill MN, Gorzalka BB (2009) Impairments in endocannabinoid signaling and depressive illness. JAMA 301: 1165–1166.
• Kapp BS, Pascoe JP, Bixler MA (1984) The amygdala: a  neuroanatomical systems approach to its contributions to aversive conditioning. In: Neu‑ ropsychology of Memory (Buttlers N, Squire LR Eds). Guilford: New York, NY, USA, p. 473–488.
• Kelly JP, Wrynn AS, Leonard BE (1997) The olfactory bulbectomized rat as a model of depression: an update. Pharmacol Ther 74: 299–316.
• Kruk‑Slomka M, Biala G (2016) CB1 receptors in the formation of the dif‑ ferent phases of memory‑related processes in the inhibitory avoidance test in mice. Behav Brain Res 301: 84–95.
• Kruk‑Slomka M, Dzik A, Budzynska B, Biala G (2017) Endocannabinoid sys‑ tem: the direct and indirect involvement in the memory and learning processes – a short review. Mol Neurobiol 54: 8332–8347.
• Kruk‑Slomka M, Michalak A, Biala G (2015) Antidepressant‑like effects of the cannabinoid receptor ligands in the forced swimming test in mice: Mechanism of action and possible interactions with cholinergic system. Behav Brain Res 284: 24–36.
• Krypotos A, Effting M, Kindt M, Beckers T (2015) Avoidance learning: a re‑ view of theoretical models and recent developments. Front Behav Neu‑ rosci 9: 189.
• Leonard BE, Tuite  M (1981) Anatomical, physiological, and behavioral aspects of olfactory bulbectomy in the rat. Int Rev Neurobiol 22: 251–86.
• Mackie K (2005) Cannabinoids. In: Handbook of Experimental Pharmacolo‑ gy (Pertwee RG, Ed), Springer, Berlin, Heidelberg, p. 299–325.
• Marinov M, Ivanova M, Belcheva S, Belcheva I, Tashev R (2013) Effects of acutely applied cannabinoid CB1 ligands on learning and memory in rats with a model of depression. CR Acad Bulg Sci 66 : 1331–1338.
• Marinov MD, Velikova MS, Tashev RE, Doncheva DK (2019) Modulatory effect of cannabinoid ligands on the anxiety‑like behavior of bulbecto‑ mized rats. J IMAB. Ann Proceeding Scientific Papers 25: 2544–2548.
• Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, Hermann H, Tang J, Hofmann C, Zieglgänsberger W, Di Marzo V, Lutz B (2002) The endogenous cannabinoid system controls extinction of aver‑ sive memories. Nature 418: 530–534.
• Masini CV, Holmes PV, Freeman KG, Maki AC, Edwards GL (2004) Dopamine overflow is increased in olfactory bulbectomized rats: An in vivo microdi‑ alysis study. Physiol Behav 81: 111–119.
• McLaughlin RJ, Gobbi G (2012) Cannabinoids and emotionality: a neuro‑ anatomical perspective. Neuroscience 204: 134–144.
• Morales‑Medina JC, Iannitti T, Freeman A, Caldwell HK (2017) The olfactory bulbectomized rat as a model of depression: The hippocampal pathway. Behav Brain Res 317: 562–575.
• Ögren SO, Stiedl O (2010) Passive avoidance. In: Encyclopedia of Psycho‑ pharmacology (Stolerman IP, Ed). Berlin: Springer p. 960–967.
• Ögren SO, Stiedl O (2015) Passive avoidance. Encyclopedia of Psycho‑ pharmacology (Stolerman IP, Lawrence HP Eds). Berlin: Springer p. 1221–1222.
• Pamplona FA, Bitencourt RM, Takahashi RN (2008) Short‑ and long‑term effects of cannabinoids on the extinction of contextual fear memory in rats. Neurobiol Learn Mem 90: 290–293.
• Pellegrino LJ, Cushman AJ (1967) A stereotaxic atlas of the rat brain. New York: Appleton. Pertwee RG (2005) Inverse agonism and neutral antagonism at cannabi‑ noid CB1 receptors. Life Sci 76: 1307–1324.
• Petkov VD, Kehayov R, Belcheva S, Konstantinova E, Petkov VV, Getova D, Markovska V (1993) Memory effects of standardized extracts of Panax ginseng (G115), Ginkgo biloba (GK501) and their combination Gincosan (PHL‑00701). Planta Med 59: 106–114.
• Primeaux SD, Holmes PV (1999) Role of aversively motivated behavior in the olfactory bulbectomy syndrome. Physiol Behav 67: 41–47.
• Rachman S, Hodgson RI (1974) Synchrony and desynchrony in fear and avoidance. Behav Res Ther 12: 311–318.
• Ramirez F, Moscarello J, Ledoux J, Sears RM (2015) Active avoidance re‑ quires a serial basal amygdala to nucleus accumbens shell circuit. J Neu‑ rosci 35: 3470–3477.
• Ranieri R, Laezza C, Bifulco M, Marasco D, Malfitano AM (2016) Endocan‑ nabinoid system in neurological disorders. Recent Pat CNS Drug Discov 10: 90–112.
• Ruehle S, Rey AA, Remmers F, Lutz B (2012) The endocannabinoid system in anxiety, fear memory and habituation. J Psychopharmacol 26: 23–39.
• Segev A, Rubin AS, Abush H, Richter‑Levin G, Akirav I (2014) Cannabinoid receptor activation prevents the effects of chronic mild stress on emo‑ tional learning and LTP in a rat model of depression. Neuropsychophar‑ macology 39: 919–933.
• Sieck MH (1972) The role of the olfactory system in avoidance learning and activity. Physiol Behav 8: 705–710.
• Sink KS, Segovia KN, Collins LE, Markus EJ, Vemuri VK, Makriyannis A, Salamone JD (2010) The CB1 inverse agonist AM251, but not the CB1 antagonist AM4113, enhances retention of contextual fear conditioning in rats. Pharmacol Biochem Behav 95: 479–484.
• Smaga I, Jastrzębska J, Zaniewska  M, Bystrowska B, Gawliński D, Faron‑Górecka A, Broniowska Ż, Miszkiel J, Filip M (2017) changes in the brain endocannabinoid system in rat models of depression. Neurotox Res 31: 421–435.
• Song C, Leonard B (2005) The olfactory bulbectomised rat as a model of depression. Neurosci Biobehav Rev 29: 627–647.
• Tashev R, Ivanova  M, Toromanov T, Marinov  M, Belcheva S, Belcheva I (2010) Olfactory bulbectomy impairs active and passive avoidance learning in rats. CR Acad Bulg Sci 63: 617–622.
• van Riezen H, Leonard BE (1990) Effects of psychotropic drugs on the be‑ havior and neurochemistry of olfactory bulbectomized rats. Pharmacol Ther 47: 21–34.
• Werka T, Skår J, Ursin H (1978) Exploration and avoidance in rats with lesions in amygdala and piriform cortex. J Comp Physiol Psychol 92: 672–681.
• Wise LE, Thorpe AJ, Lichtman AH (2009) Hippocampal CB 1 receptors medi‑ ate the memory impairing effects of Δ 9‑tetrahydrocannabinol. Neuro‑ psychopharmacology 34: 2072–2080.
• Yamamoto T, Jin J, Watanabe S (1997) Characteristics of memory dysfunc‑ tion in olfactory bulbectomized rats and the effects of cholinergic drugs. Behav Brain Res 83: 57–62.
• Yehuda S, Rabinovitz S (2013) Olfactory bulbectomy as a putative model for Alzheimer’s: the protective role of essential fatty acids. Pharma Nu‑ trition 2: 12–18.
• Zanettini C, Panlilio LV, Alicki M., Goldberg SR, Haller J, Yasar S (2011) Ef‑ fects of endocannabinoid system modulation on cognitive and emotion‑ al behavior. Front Behav Neurosci 5: 57.

Identyfikatory

DOI

10.21307/ane‑2020‑025